Cargando…

Identifying Prognostic Biomarkers Related to m6A Modification and Immune Infiltration in Renal Cell Carcinoma

Background: Renal cell carcinoma (RCC) is the largest category of kidney tumors and usually does not have a good prognosis. N6-methyladenosine(m6A) and immune infiltration have received increased attention because of their great influence on the clinical outcome and prognosis of cancer patients. Met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Junjie, Li, Peng, Zhang, Huijiang, Wu, Qi, Yang, Dongrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690957/ https://www.ncbi.nlm.nih.gov/pubmed/36360294 http://dx.doi.org/10.3390/genes13112059

Ejemplares similares

Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma
por: Zhang, Yao-Hua, et al.
Publicado: (2022)

NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
por: Liu, Xu-Sheng, et al.
Publicado: (2021)

ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m(6)A modification, and drug susceptibility
por: Ding, Yongqi, et al.
Publicado: (2023)

STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma
por: Bai, Zi-Yuan, et al.
Publicado: (2023)

C chemokines are prognostic biomarkers correlated with diverse immune cell infiltrations in clear cell renal cell carcinoma
por: Chen, Zhiguo, et al.
Publicado: (2022)

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
por: Liu, Xu-Sheng, et al.
Publicado: (2021)

Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma
por: Sun, Ming, et al.
Publicado: (2022)

CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma
por: Wang, Feng, et al.
Publicado: (2022)

Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration
por: Nong, Ju‐sen, et al.
Publicado: (2023)

POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Tian, Junjie, et al.
Publicado: (2023)

Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma
por: Li, Na, et al.
Publicado: (2021)

FERMT1 Is a Prognostic Marker Involved in Immune Infiltration of Pancreatic Adenocarcinoma Correlating with m(6)A Modification and Necroptosis
por: Wu, Qian, et al.
Publicado: (2023)

STAT2 act a prognostic biomarker and associated with immune infiltration in kidney renal clear cell carcinoma
por: Zeng, Tao, et al.
Publicado: (2023)

Development a m(6)A regulators characterized by the immune cell infiltration in stomach adenocarcinoma for predicting the prognosis and immunotherapy response
por: Shi, Guodong, et al.
Publicado: (2023)

Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma
por: Jiayu, Fang, et al.
Publicado: (2022)

Identification of mitophagy-related biomarkers and immune infiltration in major depressive disorder
por: Zhang, Jing, et al.
Publicado: (2023)

SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma
por: Feng, Huayi, et al.
Publicado: (2022)

FDC-SP as a diagnostic and prognostic biomarker and modulates immune infiltrates in renal cell carcinoma
por: Chang, Fan, et al.
Publicado: (2023)

Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma
por: Sun, Xiaomei, et al.
Publicado: (2023)

TREM-1 as a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma
por: Pu, Yaling, et al.
Publicado: (2023)

SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2023)

Pan-cancer analysis identifies DDX56 as a prognostic biomarker associated with immune infiltration and drug sensitivity
por: Ruan, Zhaohui, et al.
Publicado: (2022)

Correction for: Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma
por: Jiayu, Fang, et al.
Publicado: (2023)

M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy
por: Zhao, Kun, et al.
Publicado: (2022)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2021)

m6A regulator-mediated methylation modification patterns and tumor microenvironment immune infiltration with prognostic analysis in esophageal cancer
por: Sheng, Gaohong, et al.
Publicado: (2023)

m(6)A-Related lncRNAs Are Potential Prognostic Biomarkers of Cervical Cancer and Affect Immune Infiltration
por: Jia, Haixia, et al.
Publicado: (2022)

An Analysis of BMP1 Associated with m6A Modification and Immune Infiltration in Pancancer
por: Zhou, Yiyi, et al.
Publicado: (2022)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Deng, Zenghua, et al.
Publicado: (2021)

ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
por: Wang, Zhen-Zhen, et al.
Publicado: (2022)

A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates
por: He, Jian, et al.
Publicado: (2022)

Prognostic biomarker CCR6 and its correlation with immune infiltration in cutaneous melanoma
por: Nurzat, Yeltai, et al.
Publicado: (2023)

M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer
por: Cai, Changjing, et al.
Publicado: (2021)

ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma
por: Zhang, Chiyu, et al.
Publicado: (2022)

Integrated analysis of immune infiltration in esophageal carcinoma as prognostic biomarkers
por: Yin, Hang, et al.
Publicado: (2021)

Identification of key biomarkers and immune infiltration in renal interstitial fibrosis
por: Hu, Zhanhong, et al.
Publicado: (2022)

Identifying prognostic characteristics of m6A-related glycolysis gene and predicting the immune infiltration landscape in bladder cancer
por: Zhou, Guanwen, et al.
Publicado: (2023)

Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma
por: Xie, Bing-fan, et al.
Publicado: (2022)

BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Li, Jianhui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_enpu0q6d5k71e98feoohdq5j9l